1
TÍTULO: Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer  Full Text
AUTORES: Burford, B; Gentry Maharaj, A; Graham, R; Allen, D; Pedersen, JW; Nudelman, AS; Blixt, O; Fourkala, EO; Bueti, D; Dawnay, A; Ford, J; Desai, R; David, L ; Trinder, P; Acres, B; Schwientek, T; Gammerman, A; Reis, CA ; Silva, L; Osorio, H ; Hallett, R; Wandall, HH; Mandel, U; Hollingsworth, MA; Jacobs, I; Fentiman, I; Clausen, H; Taylor Papadimitriou, J; Menon, U; Burchell, JM; ...Mais
PUBLICAÇÃO: 2013, FONTE: BRITISH JOURNAL OF CANCER, VOLUME: 108, NÚMERO: 10
INDEXADO EM: Scopus WOS CrossRef: 42
2
TÍTULO: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
AUTORES: Bijker, N; Peterse, JL; Duchateau, L; Julien, JP; Fentiman, IS; Duval, C; Di Palma, S; Simony Lafontaine, J; de Mascarel, I; van de Vijver, MJ;
PUBLICAÇÃO: 2001, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 19, NÚMERO: 8
INDEXADO EM: WOS